The results presented above provide evidence of the existence of substantial antienzymatic activity of several well-identified maca compounds against AChE and BuChE, thus confirming that L. peruvianum is a rich source of active glucosinolates, thus showing promise for possible application of selected maca phenotypes in developing therapeutic products for treating medical conditions related to memory impairment. This evidence concerns the gene ACHE and memory impairment.